Policy & Regulation
15 February 2019 - - US-based biopharmaceutical company Merck (NYSE: MRK) has presented interim data from the Phase 1b/2 KEYNOTE-365 umbrella trial investigating Keytruda, Merck's anti-PD-1 thera...
15 February 2019 - - The first subject has been dosed with ASP3772, US-based Affinivax, Inc.'s novel MAPS vaccine targeting Streptococcus pneumoniae (pneumococcus), the company said.
15 February 2019 - Health care supplement products Spring Pharmaceutical Group Inc (OTCQB:CYIG) stated on Thursday its net income of USD12.91m (USD0.43 per basic and diluted share) for the nine months...
15 February 2019 - Tanabe Research Laboratories USA Inc (TRL) revealed on Thursday that it has successfully submitted its first Investigational New Drug (IND) application with the US Food and Drug adm...
14 February 2019 - - US-based biotechnology company Moderna, Inc., (NASDAQ: MRNA) has received topline data from the first planned interim analysis of safety and immunogenicity from its Phase 1 study ...
14 February 2019 - - US-based biotechnology company Exelixis, Inc. (NASDAQ: EXEL) is initiating phase 1 clinical development for XL092, the first internally-discovered Exelixis compound to enter the c...